Guidance

COVID-19 antiviral treatment: Molnupiravir

Information for those who have been prescribed Molnupiravir.

Documents

Details

The to people with coronavirus (COVID-19) who are at highest risk of becoming seriously ill.

This document includes information for those who have been prescribed Molnupiravir including how long to take the medicines for, what to do if you are pregnant or breastfeeding, and how to report side effects.

Paper copies of this leaflet are available free to order or download in the following languages:

, , , , , , , , , , , , , , , , , , , , , , , , , , , , and .

An version is available to order.

A of this leaflet is available to order.

An of this leaflet is available to download.

A British sign language (BSL) video of this guide is available to or .

Health publications orderline

Immunisation Publications
UK Health Security Agency, 61 Colindale Avenue, Colindale
London
NW9 5EQ

Contact form

Telephone: 0300 123 1002

Copies of printed publications and the full range of digital resources to support the immunisation programmes can now be ordered and downloaded online. Log in to register and place your order.

Updates to this page

Published 11 February 2022
Last updated 4 May 2022 show all updates
  1. Added links to translations and alternative formats.

  2. Added British Sign Language video link.

  3. First published.

Sign up for emails or print this page